Is Woodford Patient Capital revamp enough to lure back buyers?
Shares still not a 'buy'
Neil Woodford of Woodford Investment Management
The overhaul of Woodford Patient Capital trust's (WPCT) board must go even further, according to industry commentators, as brokers continue to urge investors to think carefully about snapping up shares despite its 32% discount to net asset value (NAV).
The board of WPCT moved to address the concerns of key shareholders on Friday (28 June) by announcing a raft of measures in response to the ongoing crisis at Woodford Investment Management. Amongst...
More News
HSBC GAM promotes Radovic to lead global credit research
Head to remain in Paris to front local credit team
Brexit Blog: Johnson to meet Merkel for backstop talks
Countdown to 31 October
Tatton IM shakes up investment team
Two new hires to join firm
Fundsmith hires IFA sales director
Moves from Franklin Templeton
Tilney eyes £45bn wealth business with S&W tie-up
'Exclusive discussions'
Back to Top